Distinct Mechanisms of Activation of Stat1 and Stat3 by Platelet-Derived Growth Factor Receptor in a Cell-Free System

REFERENCES

• Aman, M. J., and J. Leonard 1997. Cytokine signaling: cytokine-inducible signaling inhibitors. Curr. Biol. 7:784–788.
   Google Scholar
• Bach, E. A., M. Auguet, and J. Schreiber 1997. The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563–591.
   PubMed Web of Science ®Google Scholar
• Briscoe, J., F. Kohlhuber, and J. Müller 1996. JAKs and STATs branch out. Trends Cell Biol. 6:336–340.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E. Jr.. 1997. STATs and gene regulation. Science 277:1630–1635.
   PubMed Web of Science ®Google Scholar
• Darnell, J. J., I. M. Kerr, and J. Stark 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421.
   PubMed Web of Science ®Google Scholar
• Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and J. Yoshimura 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921–924.
   PubMed Web of Science ®Google Scholar
• Field, J., J. Nikawa, D. Broek, B. MacDonald, L. Rodgers, I. A. Wilson, R. A. Lerner, and J. Wigler 1988. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8:2159–2165.
   PubMed Web of Science ®Google Scholar
• Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331–334.
   PubMed Web of Science ®Google Scholar
• Ivashkiv, L. B. 1995. Cytokines and STATs: how can signals achieve specificity? Immunity 3:1–4.
   PubMedGoogle Scholar
• Johnston, J. A., C. M. Bacon, M. C. Riedy, and J. O’Shea 1996. Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J. Leukoc. Biol. 60:441–452.
   PubMed Web of Science ®Google Scholar
• Leaman, D. W., S. Leung, X. Li, and J. Stark 1996. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 10:1578–1588.
   PubMed Web of Science ®Google Scholar
• Müller, M., J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. G. Harpur, G. Barbieri, B. A. Witthuhn, C. Schindler, S. Pellegrini, A. F. Wilks, J. N. Ihle, G. R. Stark, and J. Kerr 1993. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366:129–135.
   PubMed Web of Science ®Google Scholar
• Müller, M., C. Laxton, J. Briscoe, C. Schindler, T. Improta, J. E. Darnell Jr., G. R. Stark, and J. Kerr 1993. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12:4221–4228.
   PubMed Web of Science ®Google Scholar
• Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and J. Kishimoto 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924–928.
   PubMed Web of Science ®Google Scholar
• O’Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction and immunoregulation: are we there yet? Immunity 7:1–11.
   PubMedGoogle Scholar
• Sadowski, H. B., and J. Gilman 1993. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature 362:79–83.
   PubMedGoogle Scholar
• Schindler, C., J. E. Darnell Jr.. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621–651.
   PubMed Web of Science ®Google Scholar
• Shuai, K. 1994. Interferon-activated signal transduction to the nucleus. Curr. Opin. Cell Biol. 6:253–259.
   PubMedGoogle Scholar
• Sotiropoulos, A., S. Moutoussamy, N. Binart, P. A. Kelly, and J. Finidori 1995. The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of Stat 3. FEBS Lett. 369:169–172.
   PubMedGoogle Scholar
• Starr, R., T. A. Willson, E. M. Viney, L. J. L. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and J. Hilton 1997. A family of cytokine-inducible inhibitors of signaling. Nature 387:917–921.
   PubMed Web of Science ®Google Scholar
• Velazquez, L., M. Fellous, G. R. Stark, and J. Pellegrini 1992. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70:313–322.
   PubMed Web of Science ®Google Scholar
• Vignais, M.-L., H. B. Sadowski, D. Watling, N. C. Rogers, and J. Gilman 1996. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol. Cell. Biol. 16:1759–1769.
   PubMed Web of Science ®Google Scholar
• Wagner, B. J., T. E. Hayes, C. J. Hoban, and J. Cochran 1990. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9:4477–4484.
   PubMed Web of Science ®Google Scholar
• Watanabe, S., and J. Arai 1996. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr. Opin. Genet. Dev. 6:587–596.
   PubMedGoogle Scholar
• Watling, D., D. Guschin, M. Müller, O. Silvennoinen, B. A. Witthuhn, F. W. Quelle, N. C. Rogers, C. Schindler, G. R. Stark, and J. Ihle 1993. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366:166–170.
   PubMed Web of Science ®Google Scholar